补肾通淋汤对妇科腹腔镜术后尿管留置时间的干预研究

发布时间：2018-03-08 11:16

本文选题：补肾通淋汤　切入点：妇科腹腔镜手术　出处：《南京中医药大学》2014年硕士论文　论文类型：学位论文

【摘要】：目的：通过观察补肾通淋汤对妇科腹腔镜术后患者尿管留置时间及相关症状的影响,探讨补肾通淋汤对促进术后膀胱功能恢复及体质改善方面的临床疗效,为妇科围手术期相关症状的中医药干预提供新思路。方法：将2013年3月至2014年3月在江苏省中医院住院行择期腹腔镜手术,并符合本研究标准的患者60例,按照随机数字表分为中药治疗组(A组)30例和对照组(B组)30例。A组于术后6小时后开始服用中药汤剂补肾通淋汤,6小时内饮完,并于术后12小时后开始常规服用,每日一剂,早晚各1次分服,每次200ml,连服3天,术后保留导尿6小时后拔除尿管；B组于术后6小时流质饮食,通便后普通饮食,常规保留导尿24小时后拔除尿管,两组术后其他常规处理相同。分别记录两组患者拔管后首次小便时间、拔管后首次排尿后残余尿量、术后第3天残余尿量、小腹坠胀、倦怠乏力等症状积分,并于术后第1天和第3天留取尿液样本,测定两组尿常规及尿液培养情况。结果：1.临床疗效：①术后拔管后首次排尿时间,A组明显小于B(P0.05)。⑦术后第3天残余尿量,A组明显小于B组(P0.05)。③术后第1天和第3天尿常规及尿培养积分比较,A组明显优于B组(P0.05)。④术后第1天和第3天主要症状积分及症状总积分改善情况,A组明显优于B组(P0.05)。 2.安全性分析：治疗过程中对治疗组30例患者进行观察,未发现有中毒及不良反应,安全性指标的实验室检查结果前后也无异常发现。由此得出：本研究所用的药物无明显毒副作用及不良反应,对人体是安全的。结论：①补肾通淋汤能够帮助缩短患者的术后导尿时间,减少尿路感染的发生率。②补肾通淋汤还可以改善患者术后小便不利、倦怠乏力、尿路刺激症状、小腹坠胀等主要不适及相关伴随症状。③补肾通淋汤可以促进妇科腹腔镜术后患者膀胱功能的恢复,促进患者术后早日康复。
[Abstract]:Objective: to observe the effect of Bushen Tonglin decoction on urinary catheter indwelling time and related symptoms after gynecological laparoscopy, and to explore the clinical effect of Bushen Tonglin decoction on promoting the recovery of bladder function and improving physique after operation. To provide a new idea for the intervention of gynecological perioperative symptoms with traditional Chinese medicine (TCM). Methods: from March 2013 to March 2014, selected laparoscopic surgery was performed in Jiangsu Provincial Hospital of traditional Chinese Medicine, and 60 patients met the criteria of this study. According to the random number table, 30 cases in group A and 30 cases in group B were divided into treatment group and control group. Group A began to take traditional Chinese medicine decoction Bushen Tonglin decoction within 6 hours after 6 hours of operation, and began to take it regularly 12 hours after operation, once a day. Morning and evening, 200 ml / time for 3 days, after 6 hours of urinary catheterization, extubation of urethral tube in group B was performed at 6 hours after operation, followed by general diet after defecation, and removal of urinary tube after 24 hours of routine retention of urethral catheterization. The time of first urination after extubation, the amount of residual urine after extubation, the residual urine volume on the third day after extubation, the distension of the lower abdomen, fatigue, and so on were recorded in the two groups. Urine samples were collected on the 1st and 3rd day after operation to determine urine routine and urine culture. Results 1. Clinical curative effect: the first time of urination after extubation in group A was significantly less than that in group A (P 0.05.7). The residual urine volume in group A was significantly lower than that in group B (P 0.05.3) on the 1st and 3rd day after operation. The urine routine and urinary culture score in group A were significantly better than those in group A. On the 1st and 3rd day after operation, the improvement of the main symptom score and the total symptom score in group A was significantly better than that in group B (P 0.05). 2. Safety analysis: during the course of treatment, 30 patients in the treatment group were observed, and no toxic or adverse reactions were found. There were no abnormal findings before and after laboratory examination of safety indexes. It was concluded that the drugs used in this study had no obvious side effects and adverse reactions and were safe to human body. Conclusion Bushen Tonglin decoction can shorten the time of urinary catheterization and reduce the incidence of urinary tract infection. 2 Bushen Tonglin decoction can also improve the symptoms of unfavorable urination, fatigue and irritation of urinary tract. Bushen Tonglin decoction can promote the recovery of bladder function of patients after gynecological laparoscopy and promote the early recovery of patients after operation.
【学位授予单位】：南京中医药大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：R713

【参考文献】